EXO-CD24

N/A

Report date: 2025/02/28 10:17:07

Base Information

Drug NameEXO-CD24
Drug Alias NameCovenD24
ClassificationBiologics > Exosomes
Mechanisms of ActionSialic acid-binding Ig-like lectin 10 modulators
TargetsSialic acid-binding Ig-like lectin 10
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsraelGreece
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTel-Aviv Sourasky Medical CenterNano24med
China Registration ClassN/A

Develop Information

Active CompaniesNano24medTel-Aviv Sourasky Medical Center
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A